As a result, the expressions of NANOG and OCT4 were higher in patients with lymph node metastases than in those without lymph node metastases, suggesting the possibility of NANOG as a malignant prognostic marker. This evidence concerns the gene NANOG and metastatic malignant neoplasm in the lymph nodes.